You are here: Industry Insights > NIH

News List

US expands COVID-19 convalescent plasma treatment trials europeanpharmaceuticalreview
September 27, 2020
Operation Warp Speed and the NIH are funding the expansion of two trials evaluating the efficacy of convalescent plasma therapy in hospitalised COVID-19 patients.
NIH launches antithrombotics trials in COVID-19 patients europeanpharmaceuticalreview
September 16, 2020
The adaptive Phase III trials will assess whether various types and doses of blood thinners can prevent COVID-19 patients forming potentially fatal blood clots.
Plex Awarded NIH Grant to Advance Eye Drop Therapy for Cataracts americanpharmaceuticalreview
July 17, 2020
Plex Pharmaceuticals has been awarded two Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH) National Eye Institute: a $1.3 million Phase II grant (R44EY027236) and a $300,000 Phase I grant (R43EY031609).
FDA Publicly Shares Antibody Test Performance Data from Kits as Part of Validation Study americanpharmaceuticalreview
June 16, 2020
The U.S. Food and Drug Administration (FDA) publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health’s (NIH) ...
ImmunoPrecise, Integrated Biotherapeutics, NIH Collaborate to Study Structural Details of Antibodies for COVID-19 americanpharmaceuticalreview
June 09, 2020
Immunoprecise Antibodies announced it is collaborating in a multi-company effort with the laboratory of Dr. Frederick Dyda at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH) ...
COVID-19 Update: FDA Shares Antibody Test Performance Data contractpharma
June 09, 2020
Independently evaluates certain antibody tests, including antibody tests that were not the subject of an EUA or pre-EUA, and those that were under FDA review.
Neurotrope, NIH Launch Clinical Trial of Bryostatin for Alzheimer's Disease americanpharmaceuticalreview
June 08, 2020
Neurotrope announced the launch of a new long-term study of Bryostatin-1 for the treatment of patients with Alzheimer's disease (AD).
Phase IIb trial to study hydroxychloroquine and azithromycin as COVID-19 treatment launched europeanpharmaceuticalreview
May 19, 2020
A double-blind clinical trial has begun in the US to study hydroxychloroquine and azithromycin treatment in patients with COVID-19.
CytoAgents gets NIH funding to advance therapy for cytokine storm pharmaceutical-technology
May 15, 2020
Biotechnology company CytoAgents has received a grant from the US’ National Institutes of Health (NIH) to speed-up the development of GP1681 for the potential treatment of cytokine storm caused by Covid-19.
NIH panel warns against use of hydroxychloroquine to treat Covid-19 pharmaceutical-technology
April 23, 2020
A US National Institutes of Health (NIH) panel has recommended against the use of hydroxychloroquine in combination with azithromycin as a Covid-19 treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page